PROVIDER PROFILE · NPI 1740213958

Adrien EshraghiMD

OtolaryngologyMiami, FLI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

300

Unique beneficiaries

—

Total services

361

Distinct HCPCS

Medicare payment

$23K

Peer benchmark

Total Medicare services vs. 578 Otolaryngology providers in FL — bottom quintile (cohort median 1,539).

PRESCRIBING · PART D · 2024

Total Rx claims

Beneficiaries

—

Total drug cost

$4K

Distinct drugs

Brand share

27.7%

Top prescribed drugs

Ofloxacin29 claims

Ciprofloxacin Hcl/Dexameth23 claims

Meclizine Hcl20 claims

Ibuprofen11 claims

QUALITY · MIPS · 2024

Final MIPS score

87.9

Quality

78.8

Cost

71.4

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.54%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$364

Payment records

By payment type

Food and Beverage$364

Top paying entities

Food and Beverage$364

REFERRAL NETWORK

Where Adrien Eshraghi's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 8 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
KUZBYT, BRIANNA	25	30
UNIVERSITY OF MIAMI	24	72
SCAGLIONE, TRICIA	23	39
Sergio Guerreiro Audiologist · Plantation, FL	18	35
Dana Libman Audiologist · Atlanta, GA	17	27
Laboratory Corporation Of America Clinical Laboratory · Tampa, FL	16	39
NORRIS, ADAM	14	25
PUBLIC HEALTH TRUST OF MIAMI DADE COUNTY FLORIDA	12	32

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history